𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression

✍ Scribed by Kazuhiko Mishima; Yukinari Kato; Mika Kato Kaneko; Ryo Nishikawa; Takanori Hirose; Masao Matsutani

Publisher
Springer-Verlag
Year
2006
Tongue
English
Weight
562 KB
Volume
111
Category
Article
ISSN
0001-6322

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cadherin expression in glandular tumors
Cadherin expression in glandular tumors of the cervix : Aberrant P-cadherin expression as a possible marker of malignancy
✍ Aaron C. Han; Mitchell I. Edelson; Alejandro Peralta Soler; Karen A. Knudsen; Be πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 642 KB

## BACKGROUND. The cadherins are homotypic adhesion proteins that are important in cell sorting during organogenesis. Classic cadherins include several different types that show tissue specific expression. Specific tissue expression of cadherins often is preserved in neoplastic transformation, and

Expression of galectin-3 in fine-needle
Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms
✍ Hidenori Inohara; Yuichiro Honjo; Tadashi Yoshii; Shiro Akahani; Jun-ichi Yoshid πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 724 KB

## BACKGROUND. Galectin-3 is a ␀-galactoside-binding protein that has been reported to be expressed preferentially in thyroid malignancies. The current study was designed to substantiate this finding further and to establish a presurgical diagnostic modality of differentiating between benign and ma

Upregulation of HMGA2 in thyroid carcino
Upregulation of HMGA2 in thyroid carcinomas: A novel molecular marker to distinguish between benign and malignant follicular neoplasias
✍ Gazanfer Belge; Anke Meyer; Markus Klemke; KΓ€te Burchardt; Corinna Stern; Werner πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 364 KB

## Abstract The identification of molecular markers allowing to differentiate between benign and malignant thyroid tumors remains a diagnostic challenge. Herein, we have used the expression of the high mobility group protein gene __HMGA2__ and its protein, respectively, as a possible marker detecti